User contributions

From MicrobeWiki, the student-edited microbiology resource

For Smithsr (talk | block log | uploads | logs)

Search for contributions

 Show contributions of new accounts only
 IP address or username:

Namespace:  all (Main) Talk User User talk Microbewiki Microbewiki talk File File talk MediaWiki MediaWiki talk Template Template talk Help Help talk Category Category talk   Invert selection  Associated namespace 

Tag filter: 

 Only show edits that are latest revisions Only show edits that are page creations Hide minor edits

From date:

To date:

(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)

• 03:26, 19 December 2014 (diff | hist) . . (+11)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Future Research)
• 03:26, 19 December 2014 (diff | hist) . . (-16)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Conclusion)
• 03:25, 19 December 2014 (diff | hist) . . (+97)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Role of T Follicular Helper Cells in Antibody Development:)
• 03:23, 19 December 2014 (diff | hist) . . (+3)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎HIV Antibody Development in a Single Patient)
• 03:20, 19 December 2014 (diff | hist) . . (-1)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎HIV Antibody Development in a Single Patient)
• 03:20, 19 December 2014 (diff | hist) . . (0)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Common Mutations in the Structure of Primary Epitopes)
• 03:17, 19 December 2014 (diff | hist) . . (-5)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Structures of Primary HIV Antibody Epitopes)
• 03:13, 19 December 2014 (diff | hist) . . (+77)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Introduction)
• 05:04, 17 December 2014 (diff | hist) . . (+65)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Role of T Follicular Helper Cells in Antibody Development:)
• 05:03, 17 December 2014 (diff | hist) . . (+84)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Development of Broadly Neutralizing Antibodies and the Potential Role of Broadly Neutralizing Antibodies in Vaccine Development)
• 05:01, 17 December 2014 (diff | hist) . . (+84)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎HIV Antibody Development in a Single Patient)
• 05:01, 17 December 2014 (diff | hist) . . (+85)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Common Mutations in the Structure of Primary Epitopes)
• 05:00, 17 December 2014 (diff | hist) . . (+67)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Structures of Primary HIV Antibody Epitopes)
• 04:59, 17 December 2014 (diff | hist) . . (-1)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Introduction)
• 04:59, 17 December 2014 (diff | hist) . . (+76)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Introduction)
• 04:56, 17 December 2014 (diff | hist) . . (+4)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Structures of Primary HIV Antibody Epitopes)
• 04:55, 17 December 2014 (diff | hist) . . (+2)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Role of T Follicular Helper Cells in Antibody Development:)
• 04:55, 17 December 2014 (diff | hist) . . (+1)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Common Mutations in the Structure of Primary Epitopes)
• 04:55, 17 December 2014 (diff | hist) . . (+4)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Common Mutations in the Structure of Primary Epitopes)
• 04:51, 17 December 2014 (diff | hist) . . (+7)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎HIV Antibody Development in a Single Patient)
• 04:51, 17 December 2014 (diff | hist) . . (+3)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎HIV Antibody Development in a Single Patient)
• 04:50, 17 December 2014 (diff | hist) . . (+2)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Development of Broadly Neutralizing Antibodies and the Potential Role of Broadly Neutralizing Antibodies in Vaccine Development)
• 04:50, 17 December 2014 (diff | hist) . . (+3)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Role of T Follicular Helper Cells in Antibody Development:)
• 04:49, 17 December 2014 (diff | hist) . . (+1)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Future Research)
• 04:49, 17 December 2014 (diff | hist) . . (+4)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Future Research)
• 04:46, 17 December 2014 (diff | hist) . . (0)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Common Mutations in the Structure of Primary Epitopes)
• 04:45, 17 December 2014 (diff | hist) . . (0)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Common Mutations in the Structure of Primary Epitopes)
• 04:37, 17 December 2014 (diff | hist) . . (+553)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Role of T Follicular Helper Cells in Antibody Development:)
• 04:25, 17 December 2014 (diff | hist) . . (+369)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Development of Broadly Neutralizing Antibodies and the Potential Role of Broadly Neutralizing Antibodies in Vaccine Development)
• 04:17, 17 December 2014 (diff | hist) . . (+910)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎HIV Antibody Development in a Single Patient)
• 04:10, 17 December 2014 (diff | hist) . . (+788)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Common Mutations in the Structure of Primary Epitopes)
• 04:00, 17 December 2014 (diff | hist) . . (0)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Structures of Primary HIV Antibody Epitopes)
• 03:59, 17 December 2014 (diff | hist) . . (+385)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Structures of Primary HIV Antibody Epitopes)
• 03:56, 17 December 2014 (diff | hist) . . (+573)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎
• 04:42, 14 November 2014 (diff | hist) . . (+1)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎
• 00:27, 13 November 2014 (diff | hist) . . (+1)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎
• 01:44, 10 November 2014 (diff | hist) . . (+668)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎
• 01:37, 10 November 2014 (diff | hist) . . (+196)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎References)
• 01:35, 10 November 2014 (diff | hist) . . (+15)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Role of T Follicular Helper Cells in Antibody Development:)
• 01:34, 10 November 2014 (diff | hist) . . (+11)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Role of T Follicular Helper Cells in Antibody Development:)
• 01:32, 10 November 2014 (diff | hist) . . (+9)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Future Research)
• 01:31, 10 November 2014 (diff | hist) . . (+10)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Development of Broadly Neutralizing Antibodies and the Potential Role of Broadly Neutralizing Antibodies in Vaccine Development)
• 01:30, 10 November 2014 (diff | hist) . . (+9)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Development of Broadly Neutralizing Antibodies and the Potential Role of Broadly Neutralizing Antibodies in Vaccine Development)
• 01:28, 10 November 2014 (diff | hist) . . (+23)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎HIV Antibody Development in a Single Patient)
• 01:25, 10 November 2014 (diff | hist) . . (-67)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Common Mutations in the Structure of Primary Epitopes)
• 01:23, 10 November 2014 (diff | hist) . . (-2)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Structures of Primary HIV Antibody Epitopes)
• 01:21, 10 November 2014 (diff | hist) . . (+58)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Structures of Primary HIV Antibody Epitopes)
• 01:18, 10 November 2014 (diff | hist) . . (+7)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎Introduction)
• 01:13, 10 November 2014 (diff | hist) . . (-4)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎References)
• 01:00, 10 November 2014 (diff | hist) . . (+1,074)‎ . . The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development ‎ (→‎References)

(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)